Natalja Eigėlienė

Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study

Nadia Harbeck, Priya Rastogi, Miguel Martín et al. · Annals of Oncology · 2021 · 378 citations · Full text

Medicine, Oncology, Pharmacology +16

Efficacy and safety results by age in monarchE: Adjuvant abemaciclib combined with endocrine therapy (ET) in patients with HR+, HER2-, node-positive, high-risk early breast cancer (EBC).

Erika Hamilton, Jee Hyun Kim, Natalja Eigėlienė et al. · Journal of Clinical Oncology · 2023 · 21 citations

Medicine, Oncology, Pharmacotherapy +17

Preemptive screening of DPYD as part of clinical practice: high prevalence of a novel exon 4 deletion in the Finnish population

Jatta Saarenheimo, Nesna Wahid, Natalja Eigėlienė et al. · Cancer Chemotherapy and Pharmacology · 2021 · 19 citations · Full text

Life Sciences, Genetics, Molecular Medicine +8

Effects of FGFR inhibitors TKI258, BGJ398 and AZD4547 on breast cancer cells in 2D, 3D and tissue explant cultures

Tiina E. Kähkönen, Mervi Toriseva, Nataliia Petruk et al. · Cellular Oncology · 2020 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT

Vasileios Karagiannis, Viktor Wichmann, Juha Saarinen et al. · Radiation Oncology · 2022 · 14 citations · Full text

Medicine, Oncology, Radiation Oncology +17